Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Novel Biomarkers for Early Detection of Ovarian Cancer in High-risk and Normal-risk Populations Using Uterine Lavage

NCT03150121 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT03150121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03150121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Novel Biomarkers for Early Detection of Ovarian Cancer in High-risk and Normal-risk Populations Using Uterine Lavage
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
June 29, 2014
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, ovarian carcinoma, primary peritoneal carcinoma, serous cystadenocarcinoma